Vera Almeida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Vera Almeida has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Ana Teixeira
UCIBIO, Applied Molecular Biosciences Unit, i4HB, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, No. 228, 4050-313 Porto, Portugal
14 shared publications - Maribel Teixeira
Associate Laboratory i4HB, Institute for Health and Bioeconomy, CESPU University, 4585-116 Gandra, Portugal
12 shared publications - Isabel Filipa Almeida
Associate Laboratory i4HB—Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
11 shared publications - José Carlos Rocha
University Institute of Health Sciences - CESPU
6 shared publications - José Manuel Sousa Lobo
UCIBIO—Applied Molecular Biosciences Unit, MedTech, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
6 shared publications - Maria Alzira Pimenta Dinis
University Fernando Pessoa (UFP), Porto, Portugal
4 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (22) , 3838
Exploring Body Image and Support Needs in Women with Breast Cancer Experiencing Treatment-Related Dermatological Side Effects: A Focus Group Study
Background/Objectives: Cancer and its treatments are frequently associated with visible dermatological changes that can affect body image, emotional well-being, and quality of life. This exploratory qualitative study aimed to examine the experiences of women with breast cancer who had experienced treatment-related dermatological side effects, with particular attention to their perceived impact on body image and psychosocial well-being, and to explore unmet needs and patient-identified priorities that may inform future supportive care and psychosocial intervention development. Methods: Two semi-structured focus groups were conducted with nine women with breast cancer who had experienced visible treatment-related dermatological side effects and were recruited through the MamaHelp Association. Data were collected using a semi-structured interview guide and analyzed through thematic analysis with investigator triangulation. Results: Five overarching themes were identified: (1) the disruptive impact of visible physical changes; (2) emotional and psychological distress; (3) coping strategies and resilience; (4) perceived support; and (5) patient-identified priorities for future interventions. Alopecia was identified as the most symbolically significant treatment-related change, being closely associated with loss of identity and femininity. Participants emphasized the need for timely psychological support, practical coping strategies, multidisciplinary care, and peer support. Conclusions: Treatment-related dermatological changes were described as affecting body image, emotional well-being, and social functioning among the women participating in this study. Participants identified unmet needs related to psychological support, practical guidance, multidisciplinary care, and peer and family support. These findings may help inform further research examining supportive-care needs and the development of psychosocial approaches addressing body image in women with breast cancer.
- 10 November 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (22) , 3838
Open AccessExploring Body Image and Support Needs in Women with Breast Cancer Experiencing Treatment-Related Dermatological Side Effects: A Focus Group Study
Background/Objectives: Cancer and its treatments are frequently associated with visible dermatological changes that can affect body image, emotional well-being, and quality of life. This exploratory qualitative study aimed to examine the experiences of women with breast cancer who had experienced treatment-related dermatological side effects, with particular attention to their perceived impact on body image and psychosocial well-being, and to explore unmet needs and patient-identified priorities that may inform future supportive care and psychosocial intervention development. Methods: Two semi-structured focus groups were conducted with nine women with breast cancer who had experienced visible treatment-related dermatological side effects and were recruited through the MamaHelp Association. Data were collected using a semi-structured interview guide and analyzed through thematic analysis with investigator triangulation. Results: Five overarching themes were identified: (1) the disruptive impact of visible physical changes; (2) emotional and psychological distress; (3) coping strategies and resilience; (4) perceived support; and (5) patient-identified priorities for future interventions. Alopecia was identified as the most symbolically significant treatment-related change, being closely associated with loss of identity and femininity. Participants emphasized the need for timely psychological support, practical coping strategies, multidisciplinary care, and peer support. Conclusions: Treatment-related dermatological changes were described as affecting body image, emotional well-being, and social functioning among the women participating in this study. Participants identified unmet needs related to psychological support, practical guidance, multidisciplinary care, and peer and family support. These findings may help inform further research examining supportive-care needs and the development of psychosocial approaches addressing body image in women with breast cancer.
- Open Access
- 12 August 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (16) , 2514
Multidisciplinary Strategies to Manage Treatment-Related Dermatologic Toxicity and Improve Quality of Life in Cancer Patients: A Narrative Review
Background/Objectives: Dermatologic toxicities are among the most common adverse effects of anticancer therapies, including chemotherapy, targeted therapies, and immunotherapies. Although typically non-life-threatening, these conditions can significantly impair quality of life, alter body image, and lead to treatment non-adherence which may compromise health outcomes. This systematic review aims to synthesize the evidence on the incidence, severity, and management of treatment-related dermatologic toxicities, with a focus on pharmaceutical and multidisciplinary care strategies. Methods: This review followed the PRISMA 2020 guidelines. PubMed, ScienceDirect, and Cochrane were searched for studies published between 1 January 2015 and 31 December 2025. Eligibility criteria were defined using the PICO (R) framework. Study selection, data extraction, and risk-of-bias assessment were performed independently by two reviewers. Given study heterogeneity, a narrative synthesis was conducted. Results: Seventeen studies were included. Dermatologic toxicities were frequently reported during cancer treatment and were generally mild to moderate in severity, although they imposed a substantial burden on patients. Supportive dermatologic care strategies were associated with reduced symptom severity and improved quality of life in some studies. Evidence for pharmaceutical care and multidisciplinary management was more limited, and the available data do not allow firm conclusions regarding their effectiveness. Conclusions: Dermatologic toxicities remain an important challenge in oncological care. The evidence suggests potential benefits of supportive care approaches, but the certainty of the evidence is limited, particularly for pharmaceutical care. Further high-quality studies are needed to clarify the impact of these interventions and support standardized recommendations.
- 12 August 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (16) , 2514
Open AccessMultidisciplinary Strategies to Manage Treatment-Related Dermatologic Toxicity and Improve Quality of Life in Cancer Patients: A Narrative Review
Background/Objectives: Dermatologic toxicities are among the most common adverse effects of anticancer therapies, including chemotherapy, targeted therapies, and immunotherapies. Although typically non-life-threatening, these conditions can significantly impair quality of life, alter body image, and lead to treatment non-adherence which may compromise health outcomes. This systematic review aims to synthesize the evidence on the incidence, severity, and management of treatment-related dermatologic toxicities, with a focus on pharmaceutical and multidisciplinary care strategies. Methods: This review followed the PRISMA 2020 guidelines. PubMed, ScienceDirect, and Cochrane were searched for studies published between 1 January 2015 and 31 December 2025. Eligibility criteria were defined using the PICO (R) framework. Study selection, data extraction, and risk-of-bias assessment were performed independently by two reviewers. Given study heterogeneity, a narrative synthesis was conducted. Results: Seventeen studies were included. Dermatologic toxicities were frequently reported during cancer treatment and were generally mild to moderate in severity, although they imposed a substantial burden on patients. Supportive dermatologic care strategies were associated with reduced symptom severity and improved quality of life in some studies. Evidence for pharmaceutical care and multidisciplinary management was more limited, and the available data do not allow firm conclusions regarding their effectiveness. Conclusions: Dermatologic toxicities remain an important challenge in oncological care. The evidence suggests potential benefits of supportive care approaches, but the certainty of the evidence is limited, particularly for pharmaceutical care. Further high-quality studies are needed to clarify the impact of these interventions and support standardized recommendations.
- Open Access
- 17 November 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (22) , 2947
Psychological Interventions for the Treatment of Patients with Chronic Dermatoses: A Systematic Literature Review
Objectives: Chronic dermatoses are extremely prevalent and can manifest in various forms across genders and ages. Faced with the symptoms experienced by these conditions and the patient’s perception of the disease and its manifestation, it often leads to isolation and difficulty in emotional regulation. All these symptoms are associated with low quality of life, resulting in depressive and anxious symptomatology. Methods: This systematic literature review aims to study psychosocial interventions with an impact on the treatment of patients with chronic dermatoses. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed, guiding a systematic search across PubMed, Google Scholar, and PsycNet databases. The considered studies reported the impact of interventions when applied to patients with chronic dermatoses. All the studies found were published in peer-reviewed journals. Results: The analysis revealed that interventions based on mindfulness, self-compassion, and self-help showed promise, with several studies reporting reductions in disease-related suffering and improvements in quality of life. However, the results were heterogeneous, with some interventions showing no significant benefit over control conditions for specific outcomes like anxiety or appearance-related distress. Conclusions: The development of research lines to enhance knowledge in this field will allow for significant improvements in therapeutic care for patients with chronic dermatoses, aiming to support professionals in the development of integrative therapeutic strategies for these patients in their clinical practice.
- 17 November 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (22) , 2947
Open AccessPsychological Interventions for the Treatment of Patients with Chronic Dermatoses: A Systematic Literature Review
Objectives: Chronic dermatoses are extremely prevalent and can manifest in various forms across genders and ages. Faced with the symptoms experienced by these conditions and the patient’s perception of the disease and its manifestation, it often leads to isolation and difficulty in emotional regulation. All these symptoms are associated with low quality of life, resulting in depressive and anxious symptomatology. Methods: This systematic literature review aims to study psychosocial interventions with an impact on the treatment of patients with chronic dermatoses. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed, guiding a systematic search across PubMed, Google Scholar, and PsycNet databases. The considered studies reported the impact of interventions when applied to patients with chronic dermatoses. All the studies found were published in peer-reviewed journals. Results: The analysis revealed that interventions based on mindfulness, self-compassion, and self-help showed promise, with several studies reporting reductions in disease-related suffering and improvements in quality of life. However, the results were heterogeneous, with some interventions showing no significant benefit over control conditions for specific outcomes like anxiety or appearance-related distress. Conclusions: The development of research lines to enhance knowledge in this field will allow for significant improvements in therapeutic care for patients with chronic dermatoses, aiming to support professionals in the development of integrative therapeutic strategies for these patients in their clinical practice.
- Open Access
- 12 April 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (8) , 822
Influence of Clinical and Psychosocial Factors on the Adherence to Topical Treatment in Psoriasis
(1) Background: Psoriasis is a common chronic inflammatory skin disease with different manifestations, affecting the quality of life at social, emotional, and professional dimensions and requiring long-term treatment. This study aimed to investigate the effect of psychosocial and clinical factors on adherence to topical treatment in psoriasis. (2) Methods: Self-reported measures and weighing the medicines were used to assess adherence. Psychopathological symptoms were measured using the Brief Symptoms Inventory (BSI). Social and clinical factors were assessed by a sociodemographic and clinical questionnaire. Adherence to treatment with topical medication was assessed using a sample of 102 psoriasis patients. (3) Results: The explanatory models of adherence to topical treatment in psoriasis translated into positive associations between adherence and the education level (higher education) (p = 0.03; φ = 0.23), the single-family household (p = 0.01; φ = 0.44), active employment status (p = 0.05; φ = −0.19), familiar history of psoriasis (p = 0.04; φ = −0.21), and the presence of obsessive-compulsive symptoms (p = 0.01; d = 0.29). (4) Conclusions: In patients who present the characteristics identified that influence non-adherence, instructions should be reinforced to increase adherence. The experimental mortality (39.6%) reduced the sample size, representing a limitation of the study.
- 12 April 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (8) , 822
Open AccessInfluence of Clinical and Psychosocial Factors on the Adherence to Topical Treatment in Psoriasis
(1) Background: Psoriasis is a common chronic inflammatory skin disease with different manifestations, affecting the quality of life at social, emotional, and professional dimensions and requiring long-term treatment. This study aimed to investigate the effect of psychosocial and clinical factors on adherence to topical treatment in psoriasis. (2) Methods: Self-reported measures and weighing the medicines were used to assess adherence. Psychopathological symptoms were measured using the Brief Symptoms Inventory (BSI). Social and clinical factors were assessed by a sociodemographic and clinical questionnaire. Adherence to treatment with topical medication was assessed using a sample of 102 psoriasis patients. (3) Results: The explanatory models of adherence to topical treatment in psoriasis translated into positive associations between adherence and the education level (higher education) (p = 0.03; φ = 0.23), the single-family household (p = 0.01; φ = 0.44), active employment status (p = 0.05; φ = −0.19), familiar history of psoriasis (p = 0.04; φ = −0.21), and the presence of obsessive-compulsive symptoms (p = 0.01; d = 0.29). (4) Conclusions: In patients who present the characteristics identified that influence non-adherence, instructions should be reinforced to increase adherence. The experimental mortality (39.6%) reduced the sample size, representing a limitation of the study.
- Open Access
- 25 September 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (19) , 2621
Dermatological Side Effects of Cancer Treatment: Psychosocial Implications—A Systematic Review of the Literature
Cancer is a leading cause of mortality and morbidity all over the world and the second major cause of death in Portugal. Dermatological side effects resulting from cancer treatment have a psychosocial impact on patients’ lives, such as quality of life (QoL), body image, cognitive fusion and social inhibition. This systematic review aimed to explore and synthesize the psychosocial impact of dermatological side effects of cancer treatment, answering the following research objectives: (i) Do the dermatological side effects of the cancer treatment present any psychosocial impact for the patients? (ii) How does the psychosocial impact of the dermatological toxicities of the cancer treatment manifest in patients’ lives? Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed and guided a systematic search through the PubMed, Cochrane Library and PyscNet databases. The considered studies correlate dermatological side effects of cancer treatments and their psychological/psychosocial outcomes. The studies found were all published in peer-reviewed journals. The results obtained established that cancer treatment causes the most varied skin changes, consequently reducing self-esteem and QoL; disturbing body image; and contributing to cases of stress, depression and anxiety. There is still limited literature that profoundly investigates the experience of living with these skin toxicities. The development of research lines to improve knowledge in this field will allow for significant improvements in healthcare for patients undergoing cancer treatment who need to focus more on the psychosocial implications of skin toxicities. The novelty of this review lies in adding knowledge summarizing the psychosocial implications of dermatological side effects of cancer treatment to support healthcare providers in the development of integrative therapeutic strategies for these patients in their clinical practice.
- 25 September 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (19) , 2621
Open AccessDermatological Side Effects of Cancer Treatment: Psychosocial Implications—A Systematic Review of the Literature
Cancer is a leading cause of mortality and morbidity all over the world and the second major cause of death in Portugal. Dermatological side effects resulting from cancer treatment have a psychosocial impact on patients’ lives, such as quality of life (QoL), body image, cognitive fusion and social inhibition. This systematic review aimed to explore and synthesize the psychosocial impact of dermatological side effects of cancer treatment, answering the following research objectives: (i) Do the dermatological side effects of the cancer treatment present any psychosocial impact for the patients? (ii) How does the psychosocial impact of the dermatological toxicities of the cancer treatment manifest in patients’ lives? Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed and guided a systematic search through the PubMed, Cochrane Library and PyscNet databases. The considered studies correlate dermatological side effects of cancer treatments and their psychological/psychosocial outcomes. The studies found were all published in peer-reviewed journals. The results obtained established that cancer treatment causes the most varied skin changes, consequently reducing self-esteem and QoL; disturbing body image; and contributing to cases of stress, depression and anxiety. There is still limited literature that profoundly investigates the experience of living with these skin toxicities. The development of research lines to improve knowledge in this field will allow for significant improvements in healthcare for patients undergoing cancer treatment who need to focus more on the psychosocial implications of skin toxicities. The novelty of this review lies in adding knowledge summarizing the psychosocial implications of dermatological side effects of cancer treatment to support healthcare providers in the development of integrative therapeutic strategies for these patients in their clinical practice.
- Open Access
- 29 June 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (13) , 7974
The Role of Pain Inflexibility and Acceptance among Headache and Temporomandibular Disorders Patients
Temporomandibular disorders (TMD) and headache are complex. This study aims to assess the association between TMD, headache, and psychological dimensions such as psychological inflexibility and pain acceptance. The sample consisted of 120 participants following a non-probabilistic convenience sampling strategy through a direct invitation to the patients attending our facilities and their relatives (n = 61 diagnosed with headache, n = 34 diagnosed with TMD-headache, n = 25 control group). Diagnostic Criteria for Temporomandibular Disorders (DC-TMD), International Classification of Headache Disorders (ICHD-3 beta version), Chronic Pain Acceptance Questionnaire (CPAQ-8), and Psychological Inflexibility in Pain Scale (PIPS) were used as assessment tools. One-way ANOVA, multiple regression analysis (MRA), and the Johnson-Neyman approach were run by IBM SPSS, version 27 (IBM® Company, Chicago, IL, USA). The significance level was 0.05. One third of our sample presented with headache with TMD. Females were predominant. Males with headache, no systemic disease, less pain severity but higher frequency, living longer with the disease and having sensitive changes, showed higher pain acceptance. When headache occurs with TMD, women with higher education, no headache family history, less pain, and no motor changes showed higher pain acceptance. Patients with both conditions are more liable to have chronic pain and pain inflexibility. Pain intensity and willingness explain 50% of the psychological inflexibility in the headache group. In our sample, individuals suffering from both conditions show greater pain inflexibility, implicating more vivid suffering experiences, leading to altered daily decisions and actions. However, further studies are needed to highlight this possible association.
- 29 June 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (13) , 7974
Open AccessThe Role of Pain Inflexibility and Acceptance among Headache and Temporomandibular Disorders Patients
Temporomandibular disorders (TMD) and headache are complex. This study aims to assess the association between TMD, headache, and psychological dimensions such as psychological inflexibility and pain acceptance. The sample consisted of 120 participants following a non-probabilistic convenience sampling strategy through a direct invitation to the patients attending our facilities and their relatives (n = 61 diagnosed with headache, n = 34 diagnosed with TMD-headache, n = 25 control group). Diagnostic Criteria for Temporomandibular Disorders (DC-TMD), International Classification of Headache Disorders (ICHD-3 beta version), Chronic Pain Acceptance Questionnaire (CPAQ-8), and Psychological Inflexibility in Pain Scale (PIPS) were used as assessment tools. One-way ANOVA, multiple regression analysis (MRA), and the Johnson-Neyman approach were run by IBM SPSS, version 27 (IBM® Company, Chicago, IL, USA). The significance level was 0.05. One third of our sample presented with headache with TMD. Females were predominant. Males with headache, no systemic disease, less pain severity but higher frequency, living longer with the disease and having sensitive changes, showed higher pain acceptance. When headache occurs with TMD, women with higher education, no headache family history, less pain, and no motor changes showed higher pain acceptance. Patients with both conditions are more liable to have chronic pain and pain inflexibility. Pain intensity and willingness explain 50% of the psychological inflexibility in the headache group. In our sample, individuals suffering from both conditions show greater pain inflexibility, implicating more vivid suffering experiences, leading to altered daily decisions and actions. However, further studies are needed to highlight this possible association.
- Open Access
- 23 September 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (10) , 1539
Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis
The influence of the vehicle in topical treatment adherence remains to be elucidated. The aim of this study is to analyze the influence of the pharmaceutical dosage form on adherence to topical treatment in psoriasis patients, taking into consideration the mechanical features. The adherence was evaluated in a sample of 102 psoriasis patients, followed for approximately 45 days. Adherence was calculated with a new combined methodology using a log and medication weights. The effect of the group formulation was evaluated using logistic regression models. A complex effect of the vehicle on adherence was found, mediated by the affected area. The adherence was significantly higher for patients applying gels and creams than for those using ointments, whenever the body area affected was extensive. The opposite was found when the affected area was small. Mechanical properties can partially explain the findings since gels and creams may be easier to apply. Patient beliefs and preferences regarding vehicles and their sensory attributes might also explain the results. It is noteworthy that adherence was strikingly low, with more than 75% non-adherent patients. This real-world evidence provides an insight for pharmaceutical industries and guidance for treatment prescription by physicians aiming to address the public health emergency of treatment non-adherence.
- 23 September 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (10) , 1539
Open AccessDoes the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis
The influence of the vehicle in topical treatment adherence remains to be elucidated. The aim of this study is to analyze the influence of the pharmaceutical dosage form on adherence to topical treatment in psoriasis patients, taking into consideration the mechanical features. The adherence was evaluated in a sample of 102 psoriasis patients, followed for approximately 45 days. Adherence was calculated with a new combined methodology using a log and medication weights. The effect of the group formulation was evaluated using logistic regression models. A complex effect of the vehicle on adherence was found, mediated by the affected area. The adherence was significantly higher for patients applying gels and creams than for those using ointments, whenever the body area affected was extensive. The opposite was found when the affected area was small. Mechanical properties can partially explain the findings since gels and creams may be easier to apply. Patient beliefs and preferences regarding vehicles and their sensory attributes might also explain the results. It is noteworthy that adherence was strikingly low, with more than 75% non-adherent patients. This real-world evidence provides an insight for pharmaceutical industries and guidance for treatment prescription by physicians aiming to address the public health emergency of treatment non-adherence.
- Open Access
- 12 March 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (6) , 2928
Knowledge and Practices of Community Pharmacists in Topical Dermatological Treatments
The connection between pharmacists’ knowledge and practice on the provided information to patients about dermatoses and their treatment is insufficiently characterized. Furthermore, pharmacists’ contributions in counselling and in promoting adherence to topical treatment is not fully understood. This study has three main objectives. It aims to identify the knowledge and practices of pharmacists about dermatoses and their treatment, and to compare the perspective of pharmacists with that of patients regarding treatment information, with the future goal of establishing guidelines on the communication of dosage regimen instructions to dermatological patients and promotion of adherence to treatment, filling a gap. A cross-sectional, exploratory, and descriptive study was carried out. Based on experts’ prior knowledge and extensive collected literature information, two questionnaire protocols, one for pharmacists and another one for patients, were designed. Exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) were carried out in relation to the pharmacists’ questionnaire for instrument validation. The results indicate that knowledge of pharmacists regarding dermatoses and their treatment is considered acceptable. Most of the pharmacists were reported to provide information to patients. Oppositely, patients reported not to have receive it. This is an important issue because pharmacists play a primary role in the management of several diseases. As non-adherence can be triggered by poor understanding of the dosing instructions, pharmacists’ communication practices play an important role in improving this hinderance. Results from this study identified pharmacist–patient communication gaps, so the development of guidelines to improve the transmission of clear dosage regimen instructions and knowledge about patient’s disease are of paramount importance. Training programs for continuous education of pharmacist should be implemented to solve the identified communication problems found in this study.
- 12 March 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (6) , 2928
Open AccessKnowledge and Practices of Community Pharmacists in Topical Dermatological Treatments
The connection between pharmacists’ knowledge and practice on the provided information to patients about dermatoses and their treatment is insufficiently characterized. Furthermore, pharmacists’ contributions in counselling and in promoting adherence to topical treatment is not fully understood. This study has three main objectives. It aims to identify the knowledge and practices of pharmacists about dermatoses and their treatment, and to compare the perspective of pharmacists with that of patients regarding treatment information, with the future goal of establishing guidelines on the communication of dosage regimen instructions to dermatological patients and promotion of adherence to treatment, filling a gap. A cross-sectional, exploratory, and descriptive study was carried out. Based on experts’ prior knowledge and extensive collected literature information, two questionnaire protocols, one for pharmacists and another one for patients, were designed. Exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) were carried out in relation to the pharmacists’ questionnaire for instrument validation. The results indicate that knowledge of pharmacists regarding dermatoses and their treatment is considered acceptable. Most of the pharmacists were reported to provide information to patients. Oppositely, patients reported not to have receive it. This is an important issue because pharmacists play a primary role in the management of several diseases. As non-adherence can be triggered by poor understanding of the dosing instructions, pharmacists’ communication practices play an important role in improving this hinderance. Results from this study identified pharmacist–patient communication gaps, so the development of guidelines to improve the transmission of clear dosage regimen instructions and knowledge about patient’s disease are of paramount importance. Training programs for continuous education of pharmacist should be implemented to solve the identified communication problems found in this study.
- Open Access
- 19 September 2020
- Published by MDPI AG in Behavioral Sciences
- Vol. 10 (9) , 142
The Mediator Role of Body Image-Related Cognitive Fusion in the Relationship between Disease Severity Perception, Acceptance and Psoriasis Disability
Psoriasis is a long-term skin disorder without a cure, whose patients are particularly susceptible to mental health diseases. Using a sample of patients diagnosed with psoriasis, this study aimed to: (1) identify the clinical and positive psychological variables that contribute the most to psoriasis disability and (2) assess the mediator role of body image-related cognitive fusion in the relation between disease severity perception and acceptance and self-compassion, on one hand, and psoriasis disability on the other. This is an initial cross-sectional exploratory study, with 75 patients diagnosed with psoriasis (males 52%; mean age 54.99 ± 13.72) answering a sociodemographic and a clinical questionnaire, the Psoriasis Disability Index (PDI), the Cognitive Fusion Questionnaire—Body Image (CFQ-BI), the Acceptance and Action Questionnaire—II (AAQ-II), and the Self-Compassion Scale (SCS). Descriptive and inferential statistics were used to characterize and assess the measures and the final model used. Through path analysis and a hierarchical multiple linear regression, it was found that the variables that significantly contributed to psoriasis disability were years of education, impact on social life and body image, explaining 70% of the variance. Body image-related cognitive fusion was a significant mediator in the relationship between disease severity and acceptance, and psoriasis disability. The implications of this study are considered to be extremely relevant, since it will allow additional information to be provided to psoriasis patients, appropriated to their educational level, aiming to reduce distorted perceptions of disease severity and intervene in the ability to accept this specific and important chronic health condition.
- 19 September 2020
- Published by MDPI AG in Behavioral Sciences
- Vol. 10 (9) , 142
Open AccessThe Mediator Role of Body Image-Related Cognitive Fusion in the Relationship between Disease Severity Perception, Acceptance and Psoriasis Disability
Psoriasis is a long-term skin disorder without a cure, whose patients are particularly susceptible to mental health diseases. Using a sample of patients diagnosed with psoriasis, this study aimed to: (1) identify the clinical and positive psychological variables that contribute the most to psoriasis disability and (2) assess the mediator role of body image-related cognitive fusion in the relation between disease severity perception and acceptance and self-compassion, on one hand, and psoriasis disability on the other. This is an initial cross-sectional exploratory study, with 75 patients diagnosed with psoriasis (males 52%; mean age 54.99 ± 13.72) answering a sociodemographic and a clinical questionnaire, the Psoriasis Disability Index (PDI), the Cognitive Fusion Questionnaire—Body Image (CFQ-BI), the Acceptance and Action Questionnaire—II (AAQ-II), and the Self-Compassion Scale (SCS). Descriptive and inferential statistics were used to characterize and assess the measures and the final model used. Through path analysis and a hierarchical multiple linear regression, it was found that the variables that significantly contributed to psoriasis disability were years of education, impact on social life and body image, explaining 70% of the variance. Body image-related cognitive fusion was a significant mediator in the relationship between disease severity and acceptance, and psoriasis disability. The implications of this study are considered to be extremely relevant, since it will allow additional information to be provided to psoriasis patients, appropriated to their educational level, aiming to reduce distorted perceptions of disease severity and intervene in the ability to accept this specific and important chronic health condition.
- 7 July 2020
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 26 (7) , 1703-1714
Management of skin adverse reactions in oncology
Chemo and targeted anticancer therapies present significant skin adverse reactions, which impair the patients’ quality of life. Cutaneous toxicities lead to poor treatment adherence, drug cessation, and psychosocial distress. This review aims to summarize the current knowledge concerning the prevention and management of skin toxicity arising from these therapies. A systematic literature search on online databases was conducted. The categorization of the main preventive and treatment measures was performed according to the level of evidence. Management of skin adverse reactions of oncology treatments is very heterogeneous, which can be explained by the lack of sound evidence-based treatments. The most studied adverse effects are papulopustular eruption, xerosis, and hand–foot syndrome. Prevention of xerosis stands out as the strategy most supported by level II studies. With respect to treatment, the use of antibiotics in papulopustular eruption resulting from anti-epidermal growth factor receptor agents is the most evidence-based approach. In general, the number of studies published in the literature classified with a level II of evidence (52%) is similar to the ones classified as level IV (33%), making clear the need of more randomized controlled trials regarding the effectiveness of preventive and treatment measures of skin adverse reactions of chemo and targeted anticancer therapies.
- 7 July 2020
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 26 (7) , 1703-1714
Management of skin adverse reactions in oncology
Chemo and targeted anticancer therapies present significant skin adverse reactions, which impair the patients’ quality of life. Cutaneous toxicities lead to poor treatment adherence, drug cessation, and psychosocial distress. This review aims to summarize the current knowledge concerning the prevention and management of skin toxicity arising from these therapies. A systematic literature search on online databases was conducted. The categorization of the main preventive and treatment measures was performed according to the level of evidence. Management of skin adverse reactions of oncology treatments is very heterogeneous, which can be explained by the lack of sound evidence-based treatments. The most studied adverse effects are papulopustular eruption, xerosis, and hand–foot syndrome. Prevention of xerosis stands out as the strategy most supported by level II studies. With respect to treatment, the use of antibiotics in papulopustular eruption resulting from anti-epidermal growth factor receptor agents is the most evidence-based approach. In general, the number of studies published in the literature classified with a level II of evidence (52%) is similar to the ones classified as level IV (33%), making clear the need of more randomized controlled trials regarding the effectiveness of preventive and treatment measures of skin adverse reactions of chemo and targeted anticancer therapies.